<table sstyle="width:80%" align="center" border=1>
<tr>
<th>mv</th>
<th>dw</th>
<th>HMMCrowd</th>
</tr>
<tr>
<td width=33%>
[1, 8] selective angiotensin receptor antagonist, Valsartan,<br>[27, 35] selective angiotensin II receptor blocker (ARB)<br>[101, 103] ARB valsartan<br>[108, 111] or a placebo<br></td>
<td width=33%>
[1, 8] selective angiotensin receptor antagonist, Valsartan,<br>[27, 35] selective angiotensin II receptor blocker (ARB)<br>[94, 111] 12 months' administration of either the ARB valsartan (n = 14) or a placebo<br></td>
<td width=33%>
[0, 8] A selective angiotensin receptor antagonist, Valsartan,<br>[27, 35] selective angiotensin II receptor blocker (ARB)<br>[94, 111] 12 months' administration of either the ARB valsartan (n = 14) or a placebo<br>[246, 247] ARB<br>[262, 263] placebo<br>[297, 298] ARB<br></td>
</tr>
